Clearing her throat to start the interview, it’s easy to tell Tori Lacey’s voice is stronger.
“I’ve definitely been noticing an increase in strength for sure,” the 21-year-old told Global News.
“It’s like this 200-pound weight has been lifted off our shoulder,” added Tori’s mother, Tracy Lacey.
The family was recently told they would have fully funded access to the miracle drug Spinraza.
Tori, who was diagnosed with the rare fatal disease spinal muscular atrophy (SMA) as a baby, appeared at Queen’s Park back in June to plead for her life. The focus was on Health Minister Christine Elliott, who was telling Ontario patients with SMA and their families that the province was reviewing the drug.
The protest came as Quebec and Saskatchewan had already given full access to Spinraza.
The Lacey family had already remortgaged their property to pay for the first four treatments with a cost of more than $400,000.
Tracy said the improvement in her daughter’s health has been noticeable already.
- Capital gains changes are ‘really fair,’ Freeland says, as doctors cry foul
- Ontario doctors offer solutions to help address shortage of family physicians
- ‘Dangerous message’: Experts slam anti-sunscreen claims circulating online
- ‘Trying not to die’: Tourism operators loaded with debt despite rising demand
“We’ve definitely seen an increase in strength. We can wait to see what keeps coming,” said Tracy.
“I’m able to work eight hours a day, which I couldn’t do before. I definitely have increased movement in my hands,” added Tori.
The province has approved full funding for Tori at a cost of roughly $125,000 per dose for the next year. After that time, Tori will be reassessed for further treatment.
Meanwhile, Tori said she still has high hopes though.
“I’m looking forward to finishing university, looking forward to my career, and looking forward to travelling the world,” she said.
Comments